Literature DB >> 22844105

Targeting B-cells in lupus nephritis: should cautious optimism remain?

Brad H Rovin1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22844105     DOI： 10.1093/ndt/gfs319

Source DB:  PubMed          Journal:  Nephrol Dial Transplant        ISSN： 0931-0509            Impact factor:   5.992


× No keyword cloud information.
  3 in total

Review 1.  Lupus nephritis: the evolving role of novel therapeutics.

Authors:  Brad H Rovin; Samir V Parikh
Journal:  Am J Kidney Dis       Date:  2014-01-07       Impact factor: 8.860

Review 2.  Biologics for the treatment of autoimmune renal diseases.

Authors:  Stephen R Holdsworth; Poh-Yi Gan; A Richard Kitching
Journal:  Nat Rev Nephrol       Date:  2016-03-07       Impact factor: 28.314

Review 3.  Profile of epratuzumab and its potential in the treatment of systemic lupus erythematosus.

Authors:  Hanan Al Rayes; Zahi Touma
Journal:  Drug Des Devel Ther       Date:  2014-11-17       Impact factor: 4.162
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.